OPTHALMIC LABS COPPER MANGANESE CHROMIUM injection

Land: Ástralía

Tungumál: enska

Heimild: Department of Health (Therapeutic Goods Administration)

Virkt innihaldsefni:

cupric chloride dihydrate, Quantity: 560 microgram/mL (Equivalent: copper, Qty 200 microgram/mL); manganese chloride tetrahydrate, Quantity: 740 microgram/mL (Equivalent: copper, Qty 200 microgram/mL; Equivalent: manganese, Qty 200 microgram/mL); chromic chloride hexahydrate, Quantity: 22 microgram/mL (Equivalent: copper, Qty 200 microgram/mL; Equivalent: chromium, Qty 4 microgram/mL)

Fáanlegur frá:

Phebra Pty Ltd

Lyfjaform:

Injection, intravenous infusion

Samsetning:

Excipient Ingredients: water for injections; hydrochloric acid

Stjórnsýsluleið:

Intravenous

Einingar í pakka:

5mL x 10

Gerð lyfseðils:

Not scheduled. Not considered by committee

Ábendingar:

INDICATIONS AS AT 01 JANUARY 1991 : This formulation is indicated for use as a supplement to IV solutions given for TPN. Administation of the solution in TPN solutions helps to maintain plasma levels of copper, manganese, and chromium and to prevent depletion of endogenous stores of these trace elements and subsequent deficiency symptoms.

Vörulýsing:

Visual Identification: Clear colourless solution; Container Type: Vial; Container Material: Glass; Container Life Time: 30 Months; Container Temperature: Store below 30 degrees Celsius

Leyfisstaða:

Registered

Leyfisdagur:

1991-10-14